DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0003873 | Rheumatoid Arthritis | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C1956346 | Coronary Artery Disease | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0010054 | Coronary Arteriosclerosis | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0006826 | Malignant Neoplasms | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0027651 | Neoplasms | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0007867 | Cervix Diseases | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0024299 | Lymphoma | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0006142 | Malignant neoplasm of breast | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0010068 | Coronary heart disease | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C1306459 | Primary malignant neoplasm | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0017638 | Glioma | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0007847 | Malignant tumor of cervix | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0206708 | Cervical Intraepithelial Neoplasia | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0302592 | Cervix carcinoma | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0002395 | Alzheimer's Disease | EDEM2 | 55741 | ER degradation enhancing alpha-mannosidase like protein 2 | Q9BV94 |
C0042133 | Uterine Fibroids | EDEM2 | 55741 | ER degradation enhancing alpha-mannosidase like protein 2 | Q9BV94 |
C0023267 | Fibroid Tumor | EDEM2 | 55741 | ER degradation enhancing alpha-mannosidase like protein 2 | Q9BV94 |
C0036341 | Schizophrenia | EDEM2 | 55741 | ER degradation enhancing alpha-mannosidase like protein 2 | Q9BV94 |
C0036341 | Schizophrenia | MECR | 51102 | mitochondrial trans-2-enoyl-CoA reductase | Q9BV79 |
C0029124 | Optic Atrophy | MECR | 51102 | mitochondrial trans-2-enoyl-CoA reductase | Q9BV79 |
C0013384 | Dyskinetic syndrome | MECR | 51102 | mitochondrial trans-2-enoyl-CoA reductase | Q9BV79 |
C0009402 | Colorectal Carcinoma | MECR | 51102 | mitochondrial trans-2-enoyl-CoA reductase | Q9BV79 |
C0752202 | Childhood Onset Dystonias | MECR | 51102 | mitochondrial trans-2-enoyl-CoA reductase | Q9BV79 |
C0008489 | Chorea | MECR | 51102 | mitochondrial trans-2-enoyl-CoA reductase | Q9BV79 |
C0007789 | Cerebral Palsy | MECR | 51102 | mitochondrial trans-2-enoyl-CoA reductase | Q9BV79 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024